LENLOVIQ Trademark

Trademark Overview

On Wednesday, January 14, 2026, a trademark application was filed for LENLOVIQ with the United States Patent and Trademark Office. The USPTO has given the LENLOVIQ trademark a serial number of 99595049. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, January 14, 2026. This trademark is owned by Gilead Sciences Ireland UC. The LENLOVIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of viral infection, fungal infection, HIV infection, fibrosis, liver diseases and disorders, hepatitis, hematological diseases and disorders, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, respiratory and pulmonary diseases and disorders, kidney and nephrotic diseases and disorders, arthritis, obesity, metabolic diseases and disorders and gastrointestinal diseases and disorders; Pharmaceutical preparations for the prevention of HIV infection; Pharmaceutical preparations for the treatment and prevention of HIV infection
lenloviq

General Information

Serial Number99595049
Word MarkLENLOVIQ
Filing DateWednesday, January 14, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, January 14, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of viral infection, fungal infection, HIV infection, fibrosis, liver diseases and disorders, hepatitis, hematological diseases and disorders, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, respiratory and pulmonary diseases and disorders, kidney and nephrotic diseases and disorders, arthritis, obesity, metabolic diseases and disorders and gastrointestinal diseases and disorders; Pharmaceutical preparations for the prevention of HIV infection; Pharmaceutical preparations for the treatment and prevention of HIV infection

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 14, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events

Event DateEvent Description
Wednesday, January 14, 2026NEW APPLICATION ENTERED
Wednesday, January 14, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 14, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

lenloviq disorders diseases infection preparations pharmaceutical prevention treatment kidney pulmonary nephrotic